{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:35:15Z","timestamp":1794645315502,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2334-12-385","type":"journal-article","created":{"date-parts":[[2012,12,29]],"date-time":"2012-12-29T07:26:46Z","timestamp":1356766006000},"source":"Crossref","is-referenced-by-count":21,"title":["Characteristics of multidrug-resistant tuberculosis in Namibia"],"prefix":"10.1186","volume":"12","author":[{"given":"Philip M","family":"Ricks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farai","family":"Mavhunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surbhi","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalia","family":"Indongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Zezai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren A","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"DeLuca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie S","family":"Krashin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyn K","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy H","family":"Holtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,29]]},"reference":[{"key":"2177_CR1","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1111\/j.1365-3156.2010.02581.x","volume":"15","author":"GB Migliori","year":"2010","unstructured":"Migliori GB, Dheda K, Centis R, Mwaba P, Bates M, et al: Review of multidrug-resistant and extensively drug-resistant TB: global perspectives with a focus on sub-saharan africa. Trop Med Int Health. 2010, 15: 1052-1066. 10.1111\/j.1365-3156.2010.02581.x.","journal-title":"Trop Med Int Health"},{"key":"2177_CR2","volume-title":"Guidelines for the programmatic management of drug-resistant tuberculosis","author":"World Health Organization","year":"2008","unstructured":"World Health Organization: Guidelines for the programmatic management of drug-resistant tuberculosis. 2008, Geneva, Switzerland: WHO"},{"key":"2177_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1164\/rccm.200907-0989OC","volume":"181","author":"NR Gandhi","year":"2010","unstructured":"Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, et al: HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med. 2010, 181: 80-86. 10.1164\/rccm.200907-0989OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 1","key":"2177_CR4","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1086\/518665","volume":"196","author":"C Wells","year":"2007","unstructured":"Wells C, Cegielski JP, Nelson L, Laserson K, Holtz T, et al: HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis. 2007, 196 (Suppl 1): S86-107.","journal-title":"J Infect Dis"},{"key":"2177_CR5","volume-title":"Multidrug and extensively drug-resistant TB (M\/XDR-TB): 2010 Global Report on Surveillance and Response","author":"World Health Organization","year":"2010","unstructured":"World Health Organization: Multidrug and extensively drug-resistant TB (M\/XDR-TB): 2010 Global Report on Surveillance and Response. 2010, Geneva, Switzerland: WHO"},{"key":"2177_CR6","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1086\/339818","volume":"185","author":"C Dye","year":"2002","unstructured":"Dye C, Espinal MA, Watt CJ, Mbiaga C, Williams BG: Worldwide incidence of multidrug-resistant tuberculosis. J Infect Dis. 2002, 185: 1197-2002. 10.1086\/339818.","journal-title":"J Infect Dis"},{"key":"2177_CR7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1086\/505877","volume":"194","author":"M Zignol","year":"2006","unstructured":"Zignol M, Hosseini M, Wright A, Weezenbeek C, Nunn P, et al: Global incidence of multidrug-resistant tuberculosis. J Infect Dis. 2006, 194: 479-485. 10.1086\/505877.","journal-title":"J Infect Dis"},{"key":"2177_CR8","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1086\/592991","volume":"198","author":"JR Andrews","year":"2008","unstructured":"Andrews JR, Gandhi NR, Moodley P, Shah NS, Bohlken L, et al: Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural south africa. J Infect Dis. 2008, 198: 1582-1589. 10.1086\/592991.","journal-title":"J Infect Dis"},{"key":"2177_CR9","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3201\/eid1409.061524","volume":"14","author":"Y Ben Amor","year":"2008","unstructured":"Ben Amor Y, Nemser B, Singh A, Sankin A, Schluger N: Underreported threat of multidrug-resistant tuberculosis in africa. Emerg Infect Dis. 2008, 14: 1345-1352. 10.3201\/eid1409.061524.","journal-title":"Emerg Infect Dis"},{"key":"2177_CR10","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/S0140-6736(06)69573-1","volume":"368","author":"N Gandhi","year":"2006","unstructured":"Gandhi N, Moll A, Sturm A, Pawinski R, Govender T, et al: Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of south africa. Lancet. 2006, 368: 1575-1580. 10.1016\/S0140-6736(06)69573-1.","journal-title":"Lancet"},{"key":"2177_CR11","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1086\/315054","volume":"180","author":"A van Rie","year":"1999","unstructured":"van Rie A, Warren R, Beyers N, Gie R, Classen C, et al: Transmission of a multidrug-resistant mycobacterium tuberculosis strain resembling \u2033strain W\u2033 among noninstitutionalized, human immunodeficiency virus-seronegative patients. J Infect Dis. 1999, 180: 1608-1615. 10.1086\/315054.","journal-title":"J Infect Dis"},{"key":"2177_CR12","first-page":"195","volume":"11","author":"T Victor","year":"2007","unstructured":"Victor T, Streicher E, Kewley C, Jordaan A, van der Spuy G, et al: Spread of an emerging mycobacterium tuberculosis drug-resistant strain in the western cape of south africa. Int J Tuberc Lung Dis. 2007, 11: 195-201.","journal-title":"Int J Tuberc Lung Dis"},{"key":"2177_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1089\/mdr.2009.0906","volume":"15","author":"S Diande","year":"2009","unstructured":"Diande S, Sangare L, Kouanda S, Dingtoumda BI, Mourfou A, et al: Risk factors for multidrug-resistant tuberculosis in four centers in burkina faso, west africa. Microb Drug Resist. 2009, 15: 217-221. 10.1089\/mdr.2009.0906.","journal-title":"Microb Drug Resist"},{"key":"2177_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1136\/thx.2005.045963","volume":"61","author":"A Faustini","year":"2006","unstructured":"Faustini A, Hall AJ, Perucci CA: Risk factors for multidrug resistant tuberculosis in europe: a systematic review. Thorax. 2006, 61: 158-163. 10.1136\/thx.2005.045963.","journal-title":"Thorax"},{"key":"2177_CR15","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1086\/592252","volume":"47","author":"B Temple","year":"2008","unstructured":"Temple B, Ayakaka I, Ogwang S, Nabanjja H, Kayes S, et al: Rate and amplification of drug resistance among previously-treated patients with tuberculosis in kampala, uganda. Clin Infect Dis. 2008, 47: 1126-1134. 10.1086\/592252.","journal-title":"Clin Infect Dis"},{"key":"2177_CR16","volume-title":"Revised Guidelines on the Management of Multi-Drug Resistant (MDR), Polyresistant (PR) Tuberculosis and Mycobacterium Other then Tuberculosis (MOTT)","author":"Ministry of Health and Social Services","year":"2008","unstructured":"Ministry of Health and Social Services: Revised Guidelines on the Management of Multi-Drug Resistant (MDR), Polyresistant (PR) Tuberculosis and Mycobacterium Other then Tuberculosis (MOTT). 2008, MOHSS: Republic of Namibia"},{"key":"2177_CR17","volume-title":"National Tuberculosis and Leprosy Control Programme 2008\/2009 Annual Report","author":"Ministry of Health and Social Services","year":"2010","unstructured":"Ministry of Health and Social Services: National Tuberculosis and Leprosy Control Programme 2008\/2009 Annual Report. 2010, MOHSS: Republic of Namibia"},{"key":"2177_CR18","volume-title":"National Guidelines for Management of Tuberculosis","author":"Ministry of Health and Social Services","year":"2006","unstructured":"Ministry of Health and Social Services: National Guidelines for Management of Tuberculosis. 2006, MOHSS: Republic of Namibia"},{"key":"2177_CR19","volume-title":"Tuberculosis Treatment: Guidelines for National Programmes","author":"World Health Organization","year":"2003","unstructured":"World Health Organization: Tuberculosis Treatment: Guidelines for National Programmes. 2003, Geneva, Switzerland: WHO"},{"key":"2177_CR20","volume-title":"Tuberculosis Infection Control Guidelines","author":"Ministry of Health and Social Services","year":"2008","unstructured":"Ministry of Health and Social Services: Tuberculosis Infection Control Guidelines. 2008, MOHSS: Republic of Namibia"},{"key":"2177_CR21","first-page":"949","volume":"12","author":"T Galgalo","year":"2008","unstructured":"Galgalo T, Dalal S, Cain KP, Oeltmann J, Tetteh C, et al: Tuberculosis risk among staff of a large public hospital in kenya. Int J Tuberc Lung Dis. 2008, 12: 949-954.","journal-title":"Int J Tuberc Lung Dis"},{"key":"2177_CR22","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0140-6736(05)70196-3","volume":"365","author":"V Leimane","year":"2005","unstructured":"Leimane V, Riekstina V, Holtz TH, Zarovska E, Skripconoka V, et al: Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in latvia: a retrospective cohort study. Lancet. 2005, 365: 318-326.","journal-title":"Lancet"},{"key":"2177_CR23","volume-title":"National Guidelines for Antiretroviral Therapy: Second Edition","author":"Ministry of Health and Social Services: Directorate of Special Programs","year":"2007","unstructured":"Ministry of Health and Social Services: Directorate of Special Programs: National Guidelines for Antiretroviral Therapy: Second Edition. 2007, MOHSS: Republic of Namibia"},{"key":"2177_CR24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1089\/mdr.2005.11.62","volume":"11","author":"M Casal","year":"2005","unstructured":"Casal M, Vaquero M, Rinder H, Tortoli J, Grosset J, et al: A case-control study for multidrug-resistant tuberculosis: risk factors in four european countries. Microb Drug Resist. 2005, 11: 62-67. 10.1089\/mdr.2005.11.62.","journal-title":"Microb Drug Resist"},{"key":"2177_CR25","first-page":"1120","volume":"97","author":"K Weyer","year":"2007","unstructured":"Weyer K, Brand J, Lancaster J, Levin J, van der Walt M: Determinants of multidrug-resistant tuberculosis in south africa: results from a national survey. South African Medical Journal. 2007, 97: 1120-1128.","journal-title":"South African Medical Journal"},{"key":"2177_CR26","volume-title":"Guidelines for tuberculosis treatment in adults and children in national tuberculosis programmes","author":"World Health Organization","year":"1991","unstructured":"World Health Organization: Guidelines for tuberculosis treatment in adults and children in national tuberculosis programmes. 1991, Geneva, Switzerland: WHO"},{"key":"2177_CR27","first-page":"S63","volume":"7","author":"F Adatu","year":"2003","unstructured":"Adatu F, Odeke R, Mugenyi M, Gargioni G, McCray E, et al: Implementation of the DOTS strategy for tuberculosis control in rural kiboga district, uganda, offering patients the option of treatment supervision in the community, 1998-1999. Int J Tuberc Lung Dis. 2003, 7: S63-S71.","journal-title":"Int J Tuberc Lung Dis"},{"key":"2177_CR28","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/S0140-6736(10)60492-8","volume":"375","author":"K Dheda","year":"2010","unstructured":"Dheda K, Shean K, Zumla A, Badri M, Streicher EM, et al: Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in south africa: a retrospective cohort study. Lancet. 2010, 375: 1798-1807. 10.1016\/S0140-6736(10)60492-8.","journal-title":"Lancet"},{"key":"2177_CR29","volume-title":"Report of an External Review: National Tuberculosis and Leprosy Control Programme Medium Term Plan (MTP 1)","author":"Ministry of Health and Social Services","year":"2009","unstructured":"Ministry of Health and Social Services: Report of an External Review: National Tuberculosis and Leprosy Control Programme Medium Term Plan (MTP 1). 2009, Republic of Namibia: MOHSS"},{"key":"2177_CR30","volume-title":"Global tuberculosis control - epidemiology, strategy, financing: WHO Report 2009","author":"World Health Organization","year":"2009","unstructured":"World Health Organization: Global tuberculosis control - epidemiology, strategy, financing: WHO Report 2009. 2009, Geneva, Switzerland: WHO"},{"key":"2177_CR31","volume-title":"WHO Policy on TB infection control in health-care facilities, congregate settings and households","author":"World Health Organization","year":"2009","unstructured":"World Health Organization: WHO Policy on TB infection control in health-care facilities, congregate settings and households. 2009, Geneva, Switzerland: WHO"},{"issue":"Suppl 3","key":"2177_CR32","doi-asserted-by":"publisher","first-page":"S482","DOI":"10.1086\/521121","volume":"196","author":"JR Andrews","year":"2007","unstructured":"Andrews JR, Shah NS, Gandhi N, Moll T, Friedland G: Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in south africa. J Infect Dis. 2007, 196 (Suppl 3): S482-490.","journal-title":"J Infect Dis"},{"key":"2177_CR33","doi-asserted-by":"publisher","first-page":"e5561","DOI":"10.1371\/journal.pone.0005561","volume":"4","author":"S Suchindran","year":"2009","unstructured":"Suchindran S, Brouwer ES, Van Rie A: Is HIV infection a risk factor for multi-drug resistant tuberculosis? a systematic review. PLoS One. 2009, 4: e5561-10.1371\/journal.pone.0005561.","journal-title":"PLoS One"},{"key":"2177_CR34","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1097\/00002030-199211000-00014","volume":"6","author":"MM Braun","year":"1992","unstructured":"Braun MM, Kilburn JO, Smithwick RW, Coulibaly IM, Coulibaly D, et al: HIV infection and primary resistance to antituberculosis drugs in abidjan, cote d\u2032Ivoire. AIDS. 1992, 6: 1327-1330. 10.1097\/00002030-199211000-00014.","journal-title":"AIDS"},{"key":"2177_CR35","first-page":"413","volume":"14","author":"JC Brust","year":"2010","unstructured":"Brust JC, Gandhi NR, Carrara H, Osburn G, Padayatchi N: High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-natal, south africa, 2000-2003. Int J Tuberc Lung Dis. 2010, 14: 413-419.","journal-title":"Int J Tuberc Lung Dis"},{"key":"2177_CR36","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/00002030-199603000-00009","volume":"10","author":"HJ Chum","year":"1996","unstructured":"Chum HJ, O\u2032Brien RJ, Chonde TM, Graf P, Rieder HL: An epidemiological study of tuberculosis and HIV infection in tanzania, 1991-1993. AIDS. 1996, 10: 299-309. 10.1097\/00002030-199603000-00009.","journal-title":"AIDS"},{"key":"2177_CR37","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0962-8479(92)90087-Z","volume":"73","author":"W Githui","year":"1992","unstructured":"Githui W, Nunn P, Juma E, Karimi F, Brindle R, et al: Cohort study of HIV-positive and HIV-negative tuberculosis, nairobi, kenya: comparison of bacteriological results. Tuber Lung Dis. 1992, 73: 203-209. 10.1016\/0962-8479(92)90087-Z.","journal-title":"Tuber Lung Dis"},{"key":"2177_CR38","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1056\/NEJM199502023320518","volume":"332","author":"KB Patel","year":"1995","unstructured":"Patel KB, Belmonte R, Crowe HM: Drug malabsorption and resistant tuberculosis in HIV-infected patients. N Engl J Med. 1995, 332: 336-337.","journal-title":"N Engl J Med"},{"key":"2177_CR39","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1164\/rccm.200907-0989OC","volume":"181","author":"NR Gandhi","year":"2010","unstructured":"Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, et al: HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med. 2010, 181: 80-86. 10.1164\/rccm.200907-0989OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"2177_CR40","volume-title":"Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach, 2010 revision","author":"World Health Organization","year":"2010","unstructured":"World Health Organization: Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach, 2010 revision. 2010, Geneva, Switzerland: WHO"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-12-385\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-385.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-385","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-385.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T05:46:14Z","timestamp":1548222374000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-12-385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2177"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-12-385","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]},"article-number":"385"}}